Rare diseases
Investigational molecules
Locations
Back to Poland45 clinical trials in Chrzanow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PolandStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
PolandA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
PolandA study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin
PolandA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
PolandStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
PolandComparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment
PolandStudy on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure
PolandStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
PolandStudy on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of innovative therapies like baxdrostat and dapagliflozin combinations. Research encompasses both acute and chronic conditions.
Multiple studies are evaluating novel approaches to reduce major cardiovascular events and improve patient outcomes.
Clinical investigations targeting chronic obstructive pulmonary disease and severe viral lung infections, with emphasis on testing new therapeutic agents like tezepelumab and tozorakimab.
Research focuses on improving breathing function and reducing disease exacerbations.
Advanced research in chronic kidney disease treatment, including combination therapy trials and studies on preventing surgery-associated kidney injury.
Studies aim to slow disease progression and improve outcomes in patients with kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
